246 related articles for article (PubMed ID: 30794889)
1. Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients.
Park ES; Lee AR; Kim DH; Lee JH; Yoo JJ; Ahn SH; Sim H; Park S; Kang HS; Won J; Ha YN; Shin GC; Kwon SY; Park YK; Choi BS; Lee YB; Jeong N; An Y; Ju YS; Yu SJ; Chae HB; Yu KS; Kim YJ; Yoon JH; Zoulim F; Kim KH
J Hepatol; 2019 Jun; 70(6):1093-1102. PubMed ID: 30794889
[TBL] [Abstract][Full Text] [Related]
2. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.
Khatun M; Kumar K; Baidya A; Mondal RK; Baszczyňski O; Kalčic F; Banerjee S; Dhali GK; Das K; Chowdhury A; Janeba Z; Chakrabarti S; Datta S
J Virol; 2022 Jan; 96(2):e0180021. PubMed ID: 34730399
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance.
Liu Y; Chang S; Martin R; Flaherty J; Mo H; Feierbach B
J Viral Hepat; 2021 Jan; 28(1):30-39. PubMed ID: 32894807
[TBL] [Abstract][Full Text] [Related]
4. Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.
Shirvani-Dastgerdi E; Winer BY; Celià-Terrassa T; Kang Y; Tabernero D; Yagmur E; Rodríguez-Frías F; Gregori J; Luedde T; Trautwein C; Ploss A; Tacke F
J Hepatol; 2017 Aug; 67(2):246-254. PubMed ID: 28392234
[TBL] [Abstract][Full Text] [Related]
5. Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment.
Winckelmann A; Fahnøe U; Bajpai PS; Dalegaard MI; Lundh A; Ryom L; Bukh J; Weis N
J Clin Virol; 2022 Jun; 150-151():105159. PubMed ID: 35487093
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients.
Liu Y; Liu W; Li X; Xu Z; Wang X; Li C; Chen L; Xin S; Xu D
Antivir Ther; 2014; 19(6):551-8. PubMed ID: 24710668
[TBL] [Abstract][Full Text] [Related]
7. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature.
Cho WH; Lee HJ; Bang KB; Kim SB; Song IH
World J Gastroenterol; 2018 May; 24(17):1919-1924. PubMed ID: 29740207
[TBL] [Abstract][Full Text] [Related]
8. Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.
Lavocat F; Dény P; Pichoud C; Al Hawajri N; Kitrinos K; Borroto-Esoda K; Zoulim F
J Hepatol; 2013 Oct; 59(4):684-95. PubMed ID: 23742912
[TBL] [Abstract][Full Text] [Related]
9. Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance.
Jiang D; Wang J; Zhao X; Li Y; Zhang Q; Song C; Zeng H; Wang X
Liver Int; 2020 Jan; 40(1):83-91. PubMed ID: 31498528
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
[TBL] [Abstract][Full Text] [Related]
11. Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir.
Suzuki F; Sezaki H; Hosaka T; Suzuki Y; Fujiyama S; Kawamura Y; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Mineta R; Suzuki Y; Kumada H
Hepatol Res; 2021 Apr; 51(4):503-508. PubMed ID: 33462964
[TBL] [Abstract][Full Text] [Related]
12. Distinctive HBV Replication Capacity and Susceptibility to Tenofovir Induced by a Polymerase Point Mutation in Hepatoma Cell Lines and Primary Human Hepatocytes.
Lee AR; Cho JY; Kim JC; Dezhbord M; Choo SY; Ahn CH; Kim NY; Shin JJ; Park S; Park ES; Won J; Kim DS; Lee JH; Kim KH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562603
[TBL] [Abstract][Full Text] [Related]
13. Investigation of hepatitis B virus (HBV) rtS78T/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside/nucleotide analogue treatment.
Luo D; Liu Y; Chen R; Niu M; Liu L; Li X; Li Q; Huang B; Wang J; Xu D; Lin S
Antiviral Res; 2019 Oct; 170():104579. PubMed ID: 31398372
[TBL] [Abstract][Full Text] [Related]
14. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
[TBL] [Abstract][Full Text] [Related]
15. No resistance to tenofovir disoproxil fumarate through 96 weeks of treatment in patients with lamivudine-resistant chronic hepatitis B.
Corsa AC; Liu Y; Flaherty JF; Mitchell B; Fung SK; Gane E; Miller MD; Kitrinos KM
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2106-12.e1. PubMed ID: 24929235
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
17. Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection.
Zhang X; Chen X; Wei M; Zhang C; Xu T; Liu L; Xu Z
Sci Rep; 2019 May; 9(1):8078. PubMed ID: 31147594
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations.
Choe WH; Kim K; Lee SY; Choi YM; Kwon SY; Kim JH; Kim BJ
World J Gastroenterol; 2019 Sep; 25(33):4985-4998. PubMed ID: 31543688
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of clevudine-resistant mutants of hepatitis B virus isolated from chronic hepatitis B patients.
Kwon SY; Park YK; Ahn SH; Cho ES; Choe WH; Lee CH; Kim BK; Ko SY; Choi HS; Park ES; Shin GC; Kim KH
J Virol; 2010 May; 84(9):4494-503. PubMed ID: 20164224
[TBL] [Abstract][Full Text] [Related]
20. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
